Regulatory
Orphan Drug
A drug developed for a rare disease (affecting <200,000 U.S. patients).
Definition
Orphan drug designation provides tax credits, FDA fee waivers, and market exclusivity to encourage development for rare diseases. Tesamorelin originally pursued orphan status for HIV lipodystrophy.
Back to the full peptide glossary.